Mast Therapeutics CEO Matthew Pauls' 2021 pay slips 15% to $1.6M
Mast Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 19, 2022
Mast Therapeutics reported fiscal year 2021 executive compensation information on April 19, 2022.
In 2021, three executives at Mast Therapeutics received on average a compensation package of $1.2M, a 7% decrease compared to previous year.
Average pay of disclosed executives at Mast Therapeutics
Matthew Pauls, Chief Executive Officer, received $1.6M in total, which decreased by 15% compared to 2020. 34% of Pauls' compensation, or $560K, was in salary. Pauls also received $329K in non-equity incentive plan, $286K in option awards, $444K in stock awards, as well as $22K in other compensation.
For fiscal year 2021, the median employee pay was $347,829 at Mast Therapeutics. Therefore, the ratio of Matthew Pauls' pay to the median employee pay was 5 to one.
Badrul Chowdhury, Chief Medical Officer, received a compensation package of $1M, which increased by 1% compared to previous year. 52% of the compensation package, or $541K, was in salary.
David Lowrance, Chief Financial Officer, earned $826K in 2021, a 2% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 19, 2022.